International Journal of Infectious Diseases (Aug 2022)

An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.

  • Yukihiro Yoshimura,
  • Hiroaki Sasaki,
  • Nobuyuki Miyata,
  • Kazuhito Miyazaki,
  • Koji Okudela,
  • Yoko Tateishi,
  • Hiroyuki Hayashi,
  • Ai Kawana-Tachikawa,
  • Hiromichi Iwashita,
  • Kazuho Maeda,
  • Yoko Ihama,
  • Yasuyoshi Hatayama,
  • Akihide Ryo,
  • Natsuo Tachikawa

Journal volume & issue
Vol. 121
pp. 98 – 101

Abstract

Read online

We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19.

Keywords